Cargando…

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis

Hypersalivation is one of the intractable symptoms of anti‐N‐methyl‐d‐aspartate receptor (NMDAR) encephalitis. While anticholinergic medications partially improve the hypersalivation, they can aggravate the autonomic dysfunctions associated with anti‐NMDAR encephalitis. Thus, we investigated the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jun, Jin‐Sun, Seo, Han Gil, Lee, Soon‐Tae, Chu, Kon, Lee, Sang Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682120/ https://www.ncbi.nlm.nih.gov/pubmed/29159196 http://dx.doi.org/10.1002/acn3.467

Ejemplares similares

The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications
por: Bernardo, Pia, et al.
Publicado: (2019)

Pediatric anti-NMDA receptor encephalitis is seasonal
por: Adang, Laura A, et al.
Publicado: (2014)

Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
por: Shin, Yong‐Won, et al.
Publicado: (2018)

Anaesthetic management of a patient with anti-NMDA receptor encephalitis
por: Shaikh, Mohammed Aslam, et al.
Publicado: (2015)

Occult Growing Teratoma as the Cause of Protracted Symptoms in a Patient with Anti-NMDA-Receptor Encephalitis and Prior Ovarian Teratoma Removal: Implications for Continued Monitoring and Treatment
por: Hong, Sang Bin, et al.
Publicado: (2021)

Anti-NMDA Receptor Encephalitis in a Pregnant Woman
por: Kim, Jiyoung, et al.
Publicado: (2015)

Anti-NMDA Receptor Encephalitis and Vaccination
por: Wang, Hsiuying
Publicado: (2017)

Botulinum toxin in the management of acquired motor fusion deficiency
por: Murthy, Ramesh, et al.
Publicado: (2009)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Anakinra treatment for refractory cerebral autoinflammatory responses
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Anti-NMDA-receptor antibody encephalitis in infants
por: Matoq, Amr A., et al.
Publicado: (2015)

Catatonic Syndrome in Anti-NMDA Receptor Encephalitis
por: Mythri, Starlin Vijay, et al.
Publicado: (2016)

Two Cases of Anti-NMDA Receptor Encephalitis
por: Baker, Jessa, et al.
Publicado: (2016)

Balint syndrome in anti-NMDA receptor encephalitis
por: Metzger, Aude, et al.
Publicado: (2018)

Paraneoplastic anti-NMDA receptor encephalitis in 1830?
por: Tényi, Dalma, et al.
Publicado: (2020)

Neurocritical care for Anti-NMDA receptor encephalitis
por: Lin, Kuang-Lin, et al.
Publicado: (2020)

Psychiatric Presentation of Anti-NMDA Receptor Encephalitis
por: Endres, Dominique, et al.
Publicado: (2019)

Anti-NMDA Receptor Encephalitis or Psychiatric disorder?
por: Freitas, B., et al.
Publicado: (2022)

Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis
por: Gable, M. S., et al.
Publicado: (2009)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

First reported cases of anti-NMDA receptor encephalitis in Vietnamese adolescents and adults
por: Nguyen Thi Hoang, Mai, et al.
Publicado: (2017)

Botulinum toxin‐a treatment reduces human mechanical pain sensitivity and mechanotransduction
por: Paterson, Kathryn, et al.
Publicado: (2014)

Altered cortical activation from the hand after facial botulinum toxin treatment
por: Haenzi, Sara, et al.
Publicado: (2014)

Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption in anti-NMDA receptor encephalitis
por: Chang, Haoxiao, et al.
Publicado: (2023)

A case report: anti-NMDA receptor encephalitis
por: Bhat, Pavan, et al.
Publicado: (2018)

Multifocal Stroke Complicating Anti-NMDA Receptor Encephalitis
por: Stavitsky, Zina H., et al.
Publicado: (2020)

Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis
por: Wang, Wei, et al.
Publicado: (2020)

Anesthetic care for patients with anti-NMDA receptor encephalitis
por: Al Ghamdi, Faris, et al.
Publicado: (2020)

Anti-NMDA receptor encephalitis: A case report
por: Tan, H.L.
Publicado: (2021)

Paraneoplastic encephalitis associated with renal cell carcinoma
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Reemergence of Japanese Encephalitis in South Korea, 2010–2015
por: Sunwoo, Jun-Sang, et al.
Publicado: (2016)

Telemedicine in epilepsy and encephalitis: previous research and indication guidelines in Korea
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus
por: Hirohata, Shunsei, et al.
Publicado: (2019)

The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis
por: Hümmert, Martin W., et al.
Publicado: (2023)

Monoclonal antibodies from a patient with anti‐NMDA receptor encephalitis
por: Sharma, Rashmi, et al.
Publicado: (2018)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection
por: Salovin, Amy, et al.
Publicado: (2018)

Anti-NMDA receptor encephalitis: epidemiological differences and common challenges
por: Ceanga, Mihai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g7u9t9mrb6cckl8f3rt7p82api